Anixa Biosciences Inc

Bank of New York Mellon Corp ANIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

58,271

Value ($000)

182

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	182	0.0%	58,271	12/31/2025
2025 Q3	11/3/2025	192	0.0%	58,271	9/30/2025
2025 Q2	8/5/2025	192	0.0%	58,271	6/30/2025
2025 Q1	4/29/2025	168	0.0%	58,745	3/31/2025
2024 Q4	2/4/2025	136	0.0%	58,746	12/31/2024
2024 Q3	11/12/2024	185	0.0%	58,745	9/30/2024
2024 Q2	7/25/2024	161	0.0%	73,050	6/30/2024
2024 Q1	4/25/2024	272	0.0%	87,050	3/31/2024
2023 Q4	1/29/2024	375	0.0%	96,654	12/31/2023
2023 Q3	10/24/2023	316	0.0%	96,597	9/30/2023
2023 Q2	8/3/2023	312	0.0%	97,402	6/30/2023
2023 Q1	5/9/2023	420	0.0%	97,618	3/31/2023
2022 Q4	2/14/2023	415	0.0%	97,618	12/31/2022
2022 Q3	11/14/2022	481	0.0%	97,856	9/30/2022
2022 Q2	8/15/2022	299	0.0%	97,856	6/30/2022
2022 Q1	5/11/2022	271	0.0%	98,652	3/31/2022
2021 Q4	2/11/2022	293	0.0%	98,652	12/31/2021
2021 Q3	11/18/2021	471	0.0%	98,652	9/30/2021
2021 Q2	8/11/2021	168	0.0%	43,302	6/30/2021
2021 Q1	5/13/2021	238	0.0%	50,942	3/31/2021
2020 Q4	2/9/2021	160	0.0%	51,969	12/31/2020
2020 Q3	11/12/2020	96	0.0%	39,381	9/30/2020
2020 Q2	8/12/2020	121	0.0%	39,381	6/30/2020
2020 Q1	5/6/2020	63	0.0%	39,381	3/31/2020
2019 Q4	2/14/2020	134	0.0%	40,962	12/31/2019